Novo Nordisk A/S
NONOF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $101 | $84 | $56 | $48 |
| Dep. & Amort. | $9 | $9 | $7 | $6 |
| Deferred Tax | $26 | $21 | $14 | $11 |
| Stock-Based Comp. | $2 | $2 | $2 | $1 |
| Change in WC | -$12 | -$12 | -$5 | -$9 |
| Other Non-Cash | -$5 | $5 | $6 | -$2 |
| Operating Cash Flow | $121 | $109 | $79 | $55 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$47 | -$26 | -$12 | -$7 |
| Net Acquisitions | -$82 | $0 | -$7 | -$18 |
| Inv. Purchases | -$20 | -$13 | -$10 | -$7 |
| Inv. Sales/Matur. | $24 | $8 | $7 | $1 |
| Other Inv. Act. | -$4 | -$13 | -$3 | -$1 |
| Investing Cash Flow | -$129 | -$44 | -$25 | -$32 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $73 | -$1 | -$2 | $15 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$20 | -$30 | -$24 | -$19 |
| Dividends Paid | -$44 | -$32 | -$25 | -$22 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $9 | -$63 | -$52 | -$25 |
| Forex Effect | $0 | -$0 | -$0 | $1 |
| Net Chg. in Cash | $1 | $2 | $2 | -$2 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $14 | $13 | $11 | $12 |
| End Cash | $16 | $14 | $13 | $11 |
| Free Cash Flow | $70 | $70 | $64 | $48 |